Primmune Therapeutics

San Diego, United States

Primmune Therapeutics is a Biotechnology company.

$8.6M raised

Jan 2026

Series B

Biotechnology Health Care

Top Investors

Samsara BioCapitalPolaris PartnersOberland CapitalBioRock Ventures NameBioqube Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Primmune Therapeutics

How much funding has Primmune Therapeutics raised?

Primmune Therapeutics has raised $8.6M in total funding. The most recent round was Series B. The last funding was announced in January 2026.

Who are Primmune Therapeutics's investors?

Primmune Therapeutics's investors include Samsara BioCapital, Polaris Partners, Oberland Capital, BioRock Ventures Name, Bioqube Ventures.

Where is Primmune Therapeutics headquartered?

Primmune Therapeutics is headquartered in San Diego, United States.

What does Primmune Therapeutics do?

Primmune Therapeutics is a Biotechnology company.

What stage is Primmune Therapeutics at?

Primmune Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 26, 2026.

MLA

"Primmune Therapeutics — Funding & Investors." VCBacked, January 26, 2026, https://www.vcbacked.co/company/primmune-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2026). Primmune Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/primmune-therapeutics

Wikipedia (cite web)

{{cite web |title=Primmune Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/primmune-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 26, 2026.